Seastar Medical is actively transforming its core operations by implementing advanced systems for managing critical clinical data and regulatory submissions. The company is specifically focusing on digital tools to support its Selective Cytopheretic Device (SCD) across various clinical trials and post-market surveillance. This approach ensures data integrity and regulatory adherence for its FDA-approved and investigational therapies.
This digital evolution creates dependencies on robust data governance and automated compliance workflows. Challenges arise in maintaining data accuracy across clinical trial phases and streamlining complex regulatory document processes. This page analyzes Seastar Medical's key digital transformation initiatives, their operational challenges, and potential areas for external support.
Seastar Medical Snapshot
Headquarters: Denver, USA
Number of employees: 17
Public or private: Public
Business model: B2B
Website: http://www.seastarmedical.com
Seastar Medical ICP and Buying Roles
Seastar Medical sells to healthcare institutions and clinical research organizations based on therapeutic complexity.
Who drives buying decisions
- Chief Medical Officer → Oversees clinical strategy and medical affairs
- Vice President, Operations & Product Development → Manages manufacturing, product development, and operational efficiency
- Senior Vice President, Medical Affairs & Research → Leads clinical trial execution and evidence generation
- Head of Regulatory Affairs → Directs regulatory submissions and compliance activities
Key Digital Transformation Initiatives at Seastar Medical (At a Glance)
- Clinical Data Management Platform Implementation: Centralizing and analyzing data from pivotal trials and patient registries.
- Regulatory Document Lifecycle Automation: Automating the creation, review, and submission of FDA regulatory filings.
- Post-Market Surveillance Registry Automation: Digitizing the collection and reporting of real-world patient data post-approval.
- Medical Device Quality Management System Digitization: Implementing digital controls for device design, manufacturing, and quality compliance.
Where Seastar Medical’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Clinical Data Management Systems | Clinical Data Management Platform Implementation: patient data entries contain inconsistencies before analysis. | Senior Vice President, Medical Affairs & Research, Biostatistician | Enforce data standardization rules during collection and entry validation. |
| Clinical Data Management Platform Implementation: data integration from multiple sites causes discrepancies in reporting. | Senior Vice President, Medical Affairs & Research, Head of Data Management | Standardize data models across diverse clinical sites before aggregation. | |
| Clinical Data Management Platform Implementation: audit trails do not capture full data modification history. | Head of Quality Assurance, Clinical Data Manager | Validate data changes and user access across all trial data records. | |
| Regulatory Information Management (RIM) Platforms | Regulatory Document Lifecycle Automation: document versions mismatch during team reviews. | Head of Regulatory Affairs, Regulatory Operations Manager | Enforce version control and access permissions on all regulatory documents. |
| Regulatory Document Lifecycle Automation: submission packages contain missing or incorrect forms. | Head of Regulatory Affairs, Regulatory Submissions Specialist | Detect incomplete sections in submission packages before electronic filing. | |
| Regulatory Document Lifecycle Automation: tracking approval statuses across documents relies on manual updates. | Regulatory Affairs Specialist, Process Owner | Route document approvals through predefined stages without manual tracking. | |
| Post-Market Surveillance Solutions | Post-Market Surveillance Registry Automation: real-world patient outcomes data requires manual entry. | Medical Affairs Manager, Clinical Outcomes Lead | Standardize patient outcome data capture from clinical sites into the registry. |
| Post-Market Surveillance Registry Automation: adverse event reporting does not link directly to patient records. | Head of Safety, Pharmacovigilance Specialist | Route adverse event details from intake to associated patient registry entries. | |
| Medical Device QMS Software | Medical Device Quality Management System Digitization: design control documents do not link to manufacturing specifications. | Vice President, Operations & Product Development, Quality Manager | Enforce traceability between design inputs and production outputs. |
| Medical Device Quality Management System Digitization: corrective and preventive action (CAPA) records lack consistent categorization. | Quality Assurance Specialist, CAPA Manager | Standardize CAPA classifications and root cause analysis documentation. | |
| Medical Device Quality Management System Digitization: supplier audit findings require manual consolidation before review. | Supplier Quality Manager, Head of Procurement | Consolidate supplier audit data into a centralized system for review. |
Identify when companies like Seastar Medical are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Seastar Medical’s digital transformation unique
Seastar Medical’s digital transformation prioritizes regulatory compliance and clinical data integrity above all else. Its focus on FDA approvals and Breakthrough Device Designations for its SCD therapy dictates a meticulous approach to every digital initiative. The company heavily depends on verifiable data for both pivotal trials and post-market surveillance, making data accuracy a critical operational concern. This transforms its digital strategy from general efficiency gains to highly specific, audit-ready system implementations.
Seastar Medical’s Digital Transformation: Operational Breakdown
DT Initiative 1: Clinical Data Management Platform Implementation
What the company is doing
Seastar Medical implements systems to manage and analyze vast datasets from its NEUTRALIZE-AKI pivotal trial and QUELIMMUNE SAVE Registry. This includes data collection, validation, and storage for ongoing clinical studies.
Who owns this
- Senior Vice President, Medical Affairs & Research
- Head of Clinical Operations
- Biostatistician
- Clinical Data Manager
Where It Fails
- Clinical data entries contain inconsistencies before analysis.
- Data integration from multiple clinical sites creates discrepancies in reporting.
- Audit trails do not capture full data modification history within the system.
- Patient enrollment tracking requires manual reconciliation across trial sites.
- Statistical analysis reports compile with outdated or unverified datasets.
Talk track
Noticed Seastar Medical is implementing clinical data management platforms for its trials. Been looking at how some life sciences teams are validating data at source instead of correcting errors during analysis, happy to share what we’re seeing.
DT Initiative 2: Regulatory Document Lifecycle Automation
What the company is doing
Seastar Medical automates workflows for creating, reviewing, approving, and submitting FDA-required documents. This includes documentation for Breakthrough Device Designations and PMA submissions.
Who owns this
- Head of Regulatory Affairs
- Regulatory Operations Manager
- Quality Assurance Specialist
Where It Fails
- Document versions mismatch during team reviews before final submission.
- Submission packages contain missing or incorrect forms before electronic filing.
- Tracking approval statuses across multiple documents relies on manual updates.
- Regulatory submission timelines extend due to manual document compilation.
- Cross-referencing between different regulatory documents causes delays in review.
Talk track
Looks like Seastar Medical is automating its regulatory document lifecycle. Been seeing how some medtech teams are enforcing version control and access permissions to prevent submission errors, can share what’s working if useful.
DT Initiative 3: Post-Market Surveillance Registry Automation
What the company is doing
Seastar Medical digitizes the collection, tracking, and reporting of real-world patient data from the QUELIMMUNE SAVE Registry. This ensures compliance with FDA post-market surveillance requirements.
Who owns this
- Medical Affairs Manager
- Clinical Outcomes Lead
- Head of Safety
- Pharmacovigilance Specialist
Where It Fails
- Real-world patient outcome data requires manual entry from clinical sites.
- Adverse event reporting does not link directly to patient registry records.
- Data submitted to regulatory bodies contains discrepancies from the source registry.
- Compliance reports on registry data require extensive manual aggregation.
- Patient follow-up schedules are not automatically tracked for data collection.
Talk track
Saw Seastar Medical is automating its post-market surveillance registry. Been looking at how some device manufacturers are standardizing data capture from clinical sites instead of relying on manual reconciliation, happy to share what we’re seeing.
DT Initiative 4: Medical Device Quality Management System (QMS) Digitization
What the company is doing
Seastar Medical implements digital systems for document control, corrective and preventive actions (CAPA), and audit management. This ensures compliance with medical device manufacturing and quality regulations.
Who owns this
- Vice President, Operations & Product Development
- Quality Manager
- Quality Assurance Specialist
- Head of Manufacturing
Where It Fails
- Design control documents do not link to manufacturing specifications.
- Corrective and preventive action (CAPA) records lack consistent categorization.
- Supplier audit findings require manual consolidation before review.
- Change control processes introduce delays when manual approvals are required.
- Employee training records do not automatically update with new QMS procedures.
Talk track
Noticed Seastar Medical is digitizing its Medical Device Quality Management System. Been seeing how some medtech companies are enforcing traceability between design inputs and production outputs, can share what’s working if useful.
Who Should Target Seastar Medical Right Now
This account is relevant for:
- Clinical Data Management and Analytics Platforms
- Regulatory Information Management (RIM) Systems
- Post-Market Surveillance and Patient Registry Software
- Medical Device Quality Management System (QMS) Software
- Data Integrity and Governance Platforms for Life Sciences
Not a fit for:
- Generic marketing automation tools
- Broad enterprise resource planning (ERP) systems
- Consumer-facing e-commerce platforms
- Standalone IT infrastructure solutions
When Seastar Medical Is Worth Prioritizing
Prioritize if:
- You sell tools that enforce data standardization and validation during clinical trial data collection.
- You sell platforms that automate regulatory document version control and submission integrity checks.
- You sell solutions for real-world evidence (RWE) data capture and automated post-market adverse event reporting.
- You sell QMS software that enforces traceability between medical device design and manufacturing processes.
- You sell systems that standardize CAPA classifications and streamline audit management in highly regulated environments.
Deprioritize if:
- Your solution does not address specific data integrity or regulatory compliance breakdowns.
- Your product is limited to basic document management without workflow automation capabilities.
- Your offering focuses on general business efficiency rather than specialized medical device operations.
- Your platform lacks direct integrations with clinical trial systems or regulatory submission portals.
Who Can Sell to Seastar Medical Right Now
Clinical Data Management Systems
Veeva Systems - This company provides cloud-based software for the global life sciences industry, including clinical data management.
Why they are relevant: Seastar Medical's clinical data entries contain inconsistencies before analysis, and data integration from multiple sites causes discrepancies. Veeva's platform can centralize and standardize clinical trial data, enforcing validation rules to prevent inconsistencies and ensure accurate reporting for their NEUTRALIZE-AKI trial.
Medidata Solutions - This company offers a unified platform for clinical research, including electronic data capture and clinical trial management.
Why they are relevant: Seastar Medical struggles with audit trails that do not capture full data modification history within its clinical systems. Medidata's comprehensive platform can provide robust data governance and detailed audit trails, ensuring complete and verifiable data integrity for regulatory purposes.
Regulatory Information Management (RIM) Platforms
MasterControl - This company provides quality management and regulatory compliance software for regulated industries, including life sciences.
Why they are relevant: Seastar Medical's regulatory document versions mismatch during team reviews and submission packages contain missing forms. MasterControl can enforce stringent version control, automate document routing for approvals, and detect incomplete sections in regulatory submissions, streamlining their FDA processes.
ArisGlobal - This company offers a life sciences platform for drug development, including regulatory affairs and pharmacovigilance solutions.
Why they are relevant: Seastar Medical's tracking approval statuses across regulatory documents relies on manual updates, leading to extended submission timelines. ArisGlobal's RIM solution can automate the tracking and management of regulatory approvals, preventing delays and ensuring timely submissions for their various device indications.
Post-Market Surveillance and Patient Registry Software
IQVIA Technologies - This company delivers advanced analytics, technology solutions, and clinical research services for the life sciences sector.
Why they are relevant: Seastar Medical's real-world patient outcome data from the QUELIMMUNE SAVE Registry requires manual entry and adverse event reporting does not link directly to patient records. IQVIA can provide automated data capture tools and robust adverse event reporting functionalities, connecting directly to patient registries for comprehensive post-market surveillance.
Model N - This company offers revenue management solutions for life sciences and high tech, including compliance and contracting.
Why they are relevant: Seastar Medical needs to ensure compliance reports on registry data are accurate but currently requires extensive manual aggregation. Model N's capabilities can help automate data aggregation and reporting from surveillance registries, reducing manual effort and improving the accuracy of compliance reports for regulatory bodies.
Medical Device Quality Management System (QMS) Software
Greenlight Guru - This company provides a quality management system specifically designed for medical device companies.
Why they are relevant: Seastar Medical's design control documents do not link to manufacturing specifications, causing potential compliance risks. Greenlight Guru's purpose-built QMS can enforce traceability between design inputs and manufacturing outputs, ensuring consistent product quality and regulatory adherence.
Sparta Systems (Honeywell) - This company offers enterprise quality management software (EQMS) for highly regulated industries.
Why they are relevant: Seastar Medical's corrective and preventive action (CAPA) records lack consistent categorization, complicating root cause analysis. Sparta Systems' EQMS can standardize CAPA classifications, automate CAPA workflows, and provide better visibility into quality issues across their device production.
Final Take
Seastar Medical is scaling its medical device commercialization through rigorous clinical data management and regulatory compliance. Breakdowns are visible in manual data reconciliation, inconsistent document versioning, and disconnected quality processes. This account is a strong fit for vendors offering specialized solutions that enforce data integrity, automate regulatory workflows, and digitize QMS specific to the medical device industry.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.